Results 251 to 260 of about 140,144 (311)

Evolving treatments for Sjögren disease: current approaches and emerging targets

open access: yesInternal Medicine Journal, EarlyView.
Abstract Sjögren disease (SjD) is a prevalent systemic autoimmune condition characterised by exocrine gland dysfunction, systemic inflammation and heterogeneous organ involvement. Current management remains largely symptomatic, with no approved disease‐modifying therapies available and substantial unmet clinical need. However, advances in understanding
Mansi Bhurani   +3 more
wiley   +1 more source

Australian clinical practice guideline: diagnosis and treatment of idiopathic multicentric Castleman disease

open access: yesInternal Medicine Journal, EarlyView.
Abstract Idiopathic multicentric Castleman disease (iMCD) is a rare condition. The pathogenesis is incompletely understood; however, interleukin‐6 (IL‐6) is a major mediator. The clinical presentation is heterogeneous, from mild constitutional symptoms to severe multi‐organ failure.
Dipti Talaulikar   +16 more
wiley   +1 more source

A phase 1 study of R-GDP-venetoclax before autologous transplant in relapsed/refractory large B-cell lymphoma (CCTG LY.18). [PDF]

open access: yesBlood Neoplasia
Assouline S   +16 more
europepmc   +1 more source

Case Report: Immunotherapy-induced Felty syndrome in a patient with metastatic melanoma. [PDF]

open access: yesFront Oncol
Park LS   +5 more
europepmc   +1 more source

Sacituzumab govitecan in patients with metastatic breast cancer: pooled safety analysis of data from patients in North America, Europe, and Asia. [PDF]

open access: yesESMO Open
Rugo HS   +12 more
europepmc   +1 more source

Febrile Neutropenia

open access: yesATS Scholar
Lyon, James F.   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy